Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay

Journal of Infection in Developing Countries

Volumn 3, Issue 4, 2009, Pages 285-294

  Rizvi, Meher ^a   Fatima, Nazish ^a   Rashid, Mohd ^a   Shukla, Indu ^a   Malik, Abida ^a   Usman, Aayesha ^a   Siddiqui, Shireen ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

AmpC; Citrobacter; ESBL; Metallo beta lactamases; Serratia

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE AMPC; CEFIXIME; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CLAVULANIC ACID; EDETIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; METALLO BETA LACTAMASE; NETILMICIN; OFLOXACIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; TAZOBACTAM;

AGAR DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; CITROBACTER; CITROBACTER AMALONATICUS; CITROBACTER FREUNDII; CITROBACTER KOSERI; CONTROLLED STUDY; ENTEROBACTERIACEAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PREVALENCE; SERRATIA; SERRATIA MARCESCENS;

CITROBACTER; SERRATIA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CITROBACTER; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; SERRATIA; SERRATIA INFECTIONS;

EID: 67649464582     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.126     Document Type: Article

References (21)

1. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, et al. (2005) Evaluation of methods for AmpC beta-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 23: 120-4.
2. Thomson K S (2001) Controversies about Extended-Spectrum and AmpC Beta-Lactamases. Emerg Infect Dis 7:333-6.
3. Livermore DM and Brown (2001) Detection of 13 lactamase mediated resistance. J Antimicrob Chemother 48: S1, 59-64.
4. Chu Y-W, Afzal-Shah M, Houang ETS, Palepou M-FL, Lyon DJ, Woodward N, Livermore DM (2001) IMP-4, a novel metallo beta lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 45:710-714.
5. Livermore DM and Woodword N (2000) Carbapenemases: a problem in waiting? Curr Opin Microbiol 3:489-495.
6. Bhattacharjee A, Sen MR, Prakash P, Anupurba S (2008) Role of beta-lactamase inhibitors in enterobacterial isolates producing extended-spectrum beta lactamases. J Antibact Chemother 61: 309-314.
7. Black JA, Thomson KS, Buynak JD, Pitout JD (2005) Evaluation of beta lactamase inhibitors in disc tests for detection of plasmid-mediated AmpC beta lactamases in well characterized clinical strains of Klebsiella spp. J Clin Microbiol 43: 4168-4171.
8. Mackie and McCartney Practical medical Microbiology. 14th ed J.G. Collee, A.G. Fraser, B.P. Marmion, A. Simmons. Chapter 20. P.B. Crichton Enterobacteraceae. Escherichia, Klebsiella, Proteus and other genera. Churchill Livingstone.
9. Clinical and laboratory Standards Institute 2003. Performance standards for antimicrobial susceptibility testing: eighteenth informational supplement: Approved standards M100-S 18. Clinical and Laboratory Standards Institute, Baltimore, USA. 2008.
10. Lee KY, Chong HB, Shin YA, Yong KD, Yum JH (2001) Modified Hodge test and EDTA disc synergy tests to screen metallo beta lactamase producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 7: 88-91.
11. Clinical and Laboratory Standards Institute (2005) Performance standards for antimicrobial susceptibility testing: fifteenth informational supplement: M100-S 15. Clinical and Laboratory Standards Institute, Wayne, Pa, USA.
12. Liu C, Wang L, Tseng H, Wang N, Lee C (2007) Cefotaxime resistant Citrobacter freundii in isolates from blood in a tertiary teaching hospital in Northern Taiwan. Journal of Infection. 55: 363-368.
13. Shobha KL, Gowrish Rao S, Sigandhi Rao, Sreeja CK (2007) Prevalence of extended spectrum Beta-lactamases in urinary isolates of Escherichia coli, Klebsiella and Citrobacter species and their antimicrobial suscepibility pattern in a tertiary care hospital. Indian Journal of the Practising Doctor. 3: 2007-01-2007-02.
14. Hawkey P M (2008) Prevalence and clonality of extended-spectrum-beta lactamases in Asia. Clin Microbiol Infect 14:159-165.
15. Dunne WM and Hardin DJ (2005) Use of Several Inducer and substrate Antibiotic Combinations in a Disk Approximation Assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp, Citrobacter spp and Serratia spp. J Clin Microbiol 15: 5945-5949.
16. Tzouvelekis LS, Vatapoulos AC, Katsanis G, Tzelepi E (1999) Rare case of failure by an automated system to detect extended-spectrum beta-lactamase in a cephalosporin resistant Klebsiella pneumoniae isolate. J Clin Microbiol 37:238.
17. Steward CD, Rasheed JK Hubert SK, Biddle JW, Raney PM, Anderson GJ et al. (2001) Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the NCCLS extended-spectrum beta-lactamase detection methods. J Clin Microbiol 39: 2864-2872.
18. Jungmin Kim and Yu-Mi Lim (2005) Prevalence of Derepressed AmpC Mutants and Extended-Spectrum beta-Lactamase Producers among Clinical Isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: Dissemination of CTX-M-3, TEM-52, and SHV-12 Journal of Clin Microbiol 43: 2452-2455.
19. Bagattini M, Crispino M, Gentile F, Barretta E, Schiavone D, Boccia M C et al. (2004) A nosocomial outbreak of Serratia marcescens producing inducible AmpC-type beta-lactamase enzyme and carrying antimicrobial resistance genes within a class 1 integron. J Hosp Infect 56.
20. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP (1997) Inducible AmpC β lactamase producing gram negative bacilli from blood stream infections: frequency, antimicrobial susceptibility and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol. Infect Dis 28: 211-219.
21. Jacoby GA and Munoz-Price LS (2005) The new beta lactamases. N Engl J Med 352: 380-391.